RNA-based Therapeutics Drug Market, Global Outlook and Forecast 2023-2029
Report ID
42789
Publisher
Market Monitor Global
Published Date
07-Dec
Delivery Format
PDF
No of Report Page
148
Editor's Rating
US $3,250.00
US $4,225.00
US $4,875.00
  • Report Details 
    This research report provides a comprehensive analysis of the RNA-based Therapeutics Drug market, focusing on the current trends, market dynamics, and future prospects. The report explores the global RNA-based Therapeutics Drug market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of RNA-based Therapeutics Drug, challenges faced by the industry, and potential opportunities for market players.
The global RNA-based Therapeutics Drug market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The RNA-based Therapeutics Drug market presents opportunities for various stakeholders, including Neuromuscular Diseases, hATTR. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in RNA-based Therapeutics Drug market. Additionally, the growing consumer demand present avenues for market expansion.
The global RNA-based Therapeutics Drug market was valued at US$ 60320 million in 2022 and is projected to reach US$ 14820 million by 2029, at a CAGR of 3.9% during the forecast period.
The Nucleic Acid-Based Therapeutics Drug Market is driven by the promising potential of nucleic acid-based therapies in treating various genetic and acquired diseases, including genetic disorders, cancer, and infectious diseases. These innovative drugs utilize nucleic acids, such as DNA or RNA, to modify or regulate gene expression, correct genetic mutations, or target specific disease-associated genes. As the understanding of genomics and molecular biology advances, and personalized medicine gains traction, the demand for nucleic acid-based therapeutics continues to grow. Innovations in drug development, delivery systems, and gene editing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address delivery and stability issues, ensure long-term safety and efficacy, and navigate regulatory complexities and patient acceptance. Overcoming technical and scientific hurdles, optimizing drug delivery methods, and addressing concerns about off-target effects are ongoing challenges. Additionally, the market faces competition from conventional therapies and the need for continuous research and development to unlock the full therapeutic potential of nucleic acid-based drugs. Striking a balance between providing safe, effective, and accessible nucleic acid-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Nucleic Acid-Based Therapeutics Drug Market.
Key Features:
The research report on the RNA-based Therapeutics Drug market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the RNA-based Therapeutics Drug market.
Market Overview: The report provides a comprehensive overview of the RNA-based Therapeutics Drug market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Antisense Oligonucleotides (ASO), siRNA), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the RNA-based Therapeutics Drug market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the RNA-based Therapeutics Drug market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the RNA-based Therapeutics Drug market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments. 
Market Segmentation and Forecast: The report segment the RNA-based Therapeutics Drug market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the RNA-based Therapeutics Drug market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the RNA-based Therapeutics Drug market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for RNA-based Therapeutics Drug, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the RNA-based Therapeutics Drug market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
RNA-based Therapeutics Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
    Antisense Oligonucleotides (ASO)
    siRNA
    mRNA
Market segment by Application
    Neuromuscular Diseases
    hATTR
    COVID-19
    Other
Global RNA-based Therapeutics Drug Market Segment Percentages, By Region and Country, 2022 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Major players covered
    Sarepta Therapeutics
    Ionis Pharmaceuticals
    Alnylam
    Biogen
    Nippon Shinyaku
    Sobi
    Novartis
    BioNTech
    Pfizer
    Moderna Therapeutics
    Jazz Pharmaceuticals
    CureVac
    Regulus Therapeutics
    ProQR
    Secarna
    MiNA Therapeutics
    Sylentis
    Arrowhead
    Silence Therapeutics
    Dicerna
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA-based Therapeutics Drug, market overview.
Chapter 2: Global RNA-based Therapeutics Drug market size in revenue.
Chapter 3: Detailed analysis of RNA-based Therapeutics Drug company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA-based Therapeutics Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
  • Table Of Content 
    1 Introduction to Research & Analysis Reports
    1.1 RNA-based Therapeutics Drug Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global RNA-based Therapeutics Drug Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global RNA-based Therapeutics Drug Overall Market Size
    2.1 Global RNA-based Therapeutics Drug Market Size: 2022 VS 2029
    2.2 Global RNA-based Therapeutics Drug Market Size, Prospects & Forecasts: 2018-2029
    2.3 Key Market Trends, Opportunity, Drivers and Restraints
        2.3.1 Market Opportunities & Trends
        2.3.2 Market Drivers
        2.3.3 Market Restraints
3 Company Landscape
    3.1 Top RNA-based Therapeutics Drug Players in Global Market
    3.2 Top Global RNA-based Therapeutics Drug Companies Ranked by Revenue
    3.3 Global RNA-based Therapeutics Drug Revenue by Companies
    3.4 Top 3 and Top 5 RNA-based Therapeutics Drug Companies in Global Market, by Revenue in 2022
    3.5 Global Companies RNA-based Therapeutics Drug Product Type
    3.6 Tier 1, Tier 2 and Tier 3 RNA-based Therapeutics Drug Players in Global Market
        3.6.1 List of Global Tier 1 RNA-based Therapeutics Drug Companies
        3.6.2 List of Global Tier 2 and Tier 3 RNA-based Therapeutics Drug Companies
4 Market Sights by Product
    4.1 Overview
        4.1.1 By Type - Global RNA-based Therapeutics Drug Market Size Markets, 2022 & 2029
        4.1.2 Antisense Oligonucleotides (ASO)
        4.1.3 siRNA
        4.1.4 mRNA
    4.2 By Type - Global RNA-based Therapeutics Drug Revenue & Forecasts
        4.2.1 By Type - Global RNA-based Therapeutics Drug Revenue, 2018-2023
        4.2.2 By Type - Global RNA-based Therapeutics Drug Revenue, 2024-2029
        4.2.3 By Type - Global RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global RNA-based Therapeutics Drug Market Size, 2022 & 2029
        5.1.2 Neuromuscular Diseases
        5.1.3 hATTR
        5.1.4 COVID-19
        5.1.5 Other
    5.2 By Application - Global RNA-based Therapeutics Drug Revenue & Forecasts
        5.2.1 By Application - Global RNA-based Therapeutics Drug Revenue, 2018-2023
        5.2.2 By Application - Global RNA-based Therapeutics Drug Revenue, 2024-2029
        5.2.3 By Application - Global RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
6 Sights by Region
    6.1 By Region - Global RNA-based Therapeutics Drug Market Size, 2022 & 2029
    6.2 By Region - Global RNA-based Therapeutics Drug Revenue & Forecasts
        6.2.1 By Region - Global RNA-based Therapeutics Drug Revenue, 2018-2023
        6.2.2 By Region - Global RNA-based Therapeutics Drug Revenue, 2024-2029
        6.2.3 By Region - Global RNA-based Therapeutics Drug Revenue Market Share, 2018-2029
    6.3 North America
        6.3.1 By Country - North America RNA-based Therapeutics Drug Revenue, 2018-2029
        6.3.2 US RNA-based Therapeutics Drug Market Size, 2018-2029
        6.3.3 Canada RNA-based Therapeutics Drug Market Size, 2018-2029
        6.3.4 Mexico RNA-based Therapeutics Drug Market Size, 2018-2029
    6.4 Europe
        6.4.1 By Country - Europe RNA-based Therapeutics Drug Revenue, 2018-2029
        6.4.2 Germany RNA-based Therapeutics Drug Market Size, 2018-2029
        6.4.3 France RNA-based Therapeutics Drug Market Size, 2018-2029
        6.4.4 U.K. RNA-based Therapeutics Drug Market Size, 2018-2029
        6.4.5 Italy RNA-based Therapeutics Drug Market Size, 2018-2029
        6.4.6 Russia RNA-based Therapeutics Drug Market Size, 2018-2029
        6.4.7 Nordic Countries RNA-based Therapeutics Drug Market Size, 2018-2029
        6.4.8 Benelux RNA-based Therapeutics Drug Market Size, 2018-2029
    6.5 Asia
        6.5.1 By Region - Asia RNA-based Therapeutics Drug Revenue, 2018-2029
        6.5.2 China RNA-based Therapeutics Drug Market Size, 2018-2029
        6.5.3 Japan RNA-based Therapeutics Drug Market Size, 2018-2029
        6.5.4 South Korea RNA-based Therapeutics Drug Market Size, 2018-2029
        6.5.5 Southeast Asia RNA-based Therapeutics Drug Market Size, 2018-2029
        6.5.6 India RNA-based Therapeutics Drug Market Size, 2018-2029
    6.6 South America
        6.6.1 By Country - South America RNA-based Therapeutics Drug Revenue, 2018-2029
        6.6.2 Brazil RNA-based Therapeutics Drug Market Size, 2018-2029
        6.6.3 Argentina RNA-based Therapeutics Drug Market Size, 2018-2029
    6.7 Middle East & Africa
        6.7.1 By Country - Middle East & Africa RNA-based Therapeutics Drug Revenue, 2018-2029
        6.7.2 Turkey RNA-based Therapeutics Drug Market Size, 2018-2029
        6.7.3 Israel RNA-based Therapeutics Drug Market Size, 2018-2029
        6.7.4 Saudi Arabia RNA-based Therapeutics Drug Market Size, 2018-2029
        6.7.5 UAE RNA-based Therapeutics Drug Market Size, 2018-2029
7 RNA-based Therapeutics Drug Companies Profiles
    7.1 Sarepta Therapeutics
        7.1.1 Sarepta Therapeutics Company Summary
        7.1.2 Sarepta Therapeutics Business Overview
        7.1.3 Sarepta Therapeutics RNA-based Therapeutics Drug Major Product Offerings
        7.1.4 Sarepta Therapeutics RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.1.5 Sarepta Therapeutics Key News & Latest Developments
    7.2 Ionis Pharmaceuticals
        7.2.1 Ionis Pharmaceuticals Company Summary
        7.2.2 Ionis Pharmaceuticals Business Overview
        7.2.3 Ionis Pharmaceuticals RNA-based Therapeutics Drug Major Product Offerings
        7.2.4 Ionis Pharmaceuticals RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.2.5 Ionis Pharmaceuticals Key News & Latest Developments
    7.3 Alnylam
        7.3.1 Alnylam Company Summary
        7.3.2 Alnylam Business Overview
        7.3.3 Alnylam RNA-based Therapeutics Drug Major Product Offerings
        7.3.4 Alnylam RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.3.5 Alnylam Key News & Latest Developments
    7.4 Biogen
        7.4.1 Biogen Company Summary
        7.4.2 Biogen Business Overview
        7.4.3 Biogen RNA-based Therapeutics Drug Major Product Offerings
        7.4.4 Biogen RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.4.5 Biogen Key News & Latest Developments
    7.5 Nippon Shinyaku
        7.5.1 Nippon Shinyaku Company Summary
        7.5.2 Nippon Shinyaku Business Overview
        7.5.3 Nippon Shinyaku RNA-based Therapeutics Drug Major Product Offerings
        7.5.4 Nippon Shinyaku RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.5.5 Nippon Shinyaku Key News & Latest Developments
    7.6 Sobi
        7.6.1 Sobi Company Summary
        7.6.2 Sobi Business Overview
        7.6.3 Sobi RNA-based Therapeutics Drug Major Product Offerings
        7.6.4 Sobi RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.6.5 Sobi Key News & Latest Developments
    7.7 Novartis
        7.7.1 Novartis Company Summary
        7.7.2 Novartis Business Overview
        7.7.3 Novartis RNA-based Therapeutics Drug Major Product Offerings
        7.7.4 Novartis RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.7.5 Novartis Key News & Latest Developments
    7.8 BioNTech
        7.8.1 BioNTech Company Summary
        7.8.2 BioNTech Business Overview
        7.8.3 BioNTech RNA-based Therapeutics Drug Major Product Offerings
        7.8.4 BioNTech RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.8.5 BioNTech Key News & Latest Developments
    7.9 Pfizer
        7.9.1 Pfizer Company Summary
        7.9.2 Pfizer Business Overview
        7.9.3 Pfizer RNA-based Therapeutics Drug Major Product Offerings
        7.9.4 Pfizer RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.9.5 Pfizer Key News & Latest Developments
    7.10 Moderna Therapeutics
        7.10.1 Moderna Therapeutics Company Summary
        7.10.2 Moderna Therapeutics Business Overview
        7.10.3 Moderna Therapeutics RNA-based Therapeutics Drug Major Product Offerings
        7.10.4 Moderna Therapeutics RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.10.5 Moderna Therapeutics Key News & Latest Developments
    7.11 Jazz Pharmaceuticals
        7.11.1 Jazz Pharmaceuticals Company Summary
        7.11.2 Jazz Pharmaceuticals Business Overview
        7.11.3 Jazz Pharmaceuticals RNA-based Therapeutics Drug Major Product Offerings
        7.11.4 Jazz Pharmaceuticals RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.11.5 Jazz Pharmaceuticals Key News & Latest Developments
    7.12 CureVac
        7.12.1 CureVac Company Summary
        7.12.2 CureVac Business Overview
        7.12.3 CureVac RNA-based Therapeutics Drug Major Product Offerings
        7.12.4 CureVac RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.12.5 CureVac Key News & Latest Developments
    7.13 Regulus Therapeutics
        7.13.1 Regulus Therapeutics Company Summary
        7.13.2 Regulus Therapeutics Business Overview
        7.13.3 Regulus Therapeutics RNA-based Therapeutics Drug Major Product Offerings
        7.13.4 Regulus Therapeutics RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.13.5 Regulus Therapeutics Key News & Latest Developments
    7.14 ProQR
        7.14.1 ProQR Company Summary
        7.14.2 ProQR Business Overview
        7.14.3 ProQR RNA-based Therapeutics Drug Major Product Offerings
        7.14.4 ProQR RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.14.5 ProQR Key News & Latest Developments
    7.15 Secarna
        7.15.1 Secarna Company Summary
        7.15.2 Secarna Business Overview
        7.15.3 Secarna RNA-based Therapeutics Drug Major Product Offerings
        7.15.4 Secarna RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.15.5 Secarna Key News & Latest Developments
    7.16 MiNA Therapeutics
        7.16.1 MiNA Therapeutics Company Summary
        7.16.2 MiNA Therapeutics Business Overview
        7.16.3 MiNA Therapeutics RNA-based Therapeutics Drug Major Product Offerings
        7.16.4 MiNA Therapeutics RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.16.5 MiNA Therapeutics Key News & Latest Developments
    7.17 Sylentis
        7.17.1 Sylentis Company Summary
        7.17.2 Sylentis Business Overview
        7.17.3 Sylentis RNA-based Therapeutics Drug Major Product Offerings
        7.17.4 Sylentis RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.17.5 Sylentis Key News & Latest Developments
    7.18 Arrowhead
        7.18.1 Arrowhead Company Summary
        7.18.2 Arrowhead Business Overview
        7.18.3 Arrowhead RNA-based Therapeutics Drug Major Product Offerings
        7.18.4 Arrowhead RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.18.5 Arrowhead Key News & Latest Developments
    7.19 Silence Therapeutics
        7.19.1 Silence Therapeutics Company Summary
        7.19.2 Silence Therapeutics Business Overview
        7.19.3 Silence Therapeutics RNA-based Therapeutics Drug Major Product Offerings
        7.19.4 Silence Therapeutics RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.19.5 Silence Therapeutics Key News & Latest Developments
    7.20 Dicerna
        7.20.1 Dicerna Company Summary
        7.20.2 Dicerna Business Overview
        7.20.3 Dicerna RNA-based Therapeutics Drug Major Product Offerings
        7.20.4 Dicerna RNA-based Therapeutics Drug Revenue in Global Market (2018-2023)
        7.20.5 Dicerna Key News & Latest Developments
8 Conclusion
9 Appendix
    9.1 Note
    9.2 Examples of Clients
    9.3 Disclaimer
  • Inquiry Before Buying

    Inquiry Before Buying

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday
  • Request Sample

    Request For Sample

    Your personal details will remain secure and confidential - Privacy Policy

    WHY CHOOSE US

    Easy Access and Express Report Delivery Service
    Discover Business Growth Opportunities
    More than 10 Years Experience Employee Support
    In-depth and Comprehensive Analysis
    100+ Client Queries Handled Everyday


Our Trusted Clients
cooper.fr
koronos
waldenmedical
unioncomm.co.kr
technopathclinicaldiagnostics
toho-titanium.co.jp
straubmedical
sew-eurodrive.de
medurifarms
naperol
nvent
network.ae
petronas
saeedghodran
polyworldsys
seedplanning.co.jp
kraton
ipms.fraunhofer.de
infanttech
httpswww.castel-freres
hintoninfo
hexcel
freightways.co.nz
excelitas
Acco
aspet
brand
bmc
elevate
europ-assistance


GET IN TOUCH
Phone: +1 (415) 315-9432
Phone: +91 86698 89536
Email: inquiry@wiredrelease.com
SHORT NAVIGATION
connect with us